2011Acta Academiae Medicinae CPAFRequires access

Protective Effects of Irbesartan on Diabetic Nephropathy in Streptozotocin-induced Diabetic Rats

Fan Li-bin

Open publisher page 0 citations

Abstract

【Objective】To investigate the protective effects of irbesartan and spironolactone on the kidney in streptozotocin(STZ)-induced diabetic rats.【Methods】Sprague-Dawley rats were randomly divided into 4 groups:sham operation group,diabetic model group,irbesartan-treated group and spironolactone-treated group.Diabetes was induced by a single injection of STZ in rats.The biochemical methods were used to measure the contents of BG,Cr,BUN,U-GLU and Ccr.【Results】Modeling after the success,through the biochemical indicators result comparison,irbesartan-treated group has protection on STZ diabetic rats kidney function compared with other groups,biochemical indexes mean difference is statistically significant(P0.05),pathology examination and electron microscopy examination results are obvious curative effect.【Conclusion】Compared to the diabetic model group,irbesartan has protective effects on kidneys injure of streptozotocin-induced diabetic rats.

About this research paper

What this paper is about

【Objective】To investigate the protective effects of irbesartan and spironolactone on the kidney in streptozotocin(STZ)-induced diabetic rats.【Methods】Sprague-Dawley rats were randomly divided into 4 groups:sham operation group,diabetic model group,irbesartan-treated group and spironolactone-treated group.Diabetes was induced by a single injection of STZ in rats.The biochemical methods were used to measure the contents of BG,Cr,BUN,U-GLU and Ccr.【Results】Modeling after the success,through the biochemical indicators result comparison,irbesartan-treated group has protection on STZ diabetic rats kidney function compared with other groups,biochemical indexes mean difference is statistically significant(P0.05),pathology examination and electron microscopy examination results are obvious curative effect.【Conclusion】Compared to the diabetic model group,irbesartan has protective effects on kidneys injure of streptozotocin-induced diabetic rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

【Objective】To investigate the protective effects of irbesartan and spironolactone on the kidney in streptozotocin(STZ)-induced diabetic rats.【Methods】Sprague-Dawley rats were randomly divided into 4 groups:sham operation group,diabetic model group,irbesartan-treated group and spironolactone-treated group.Diabetes was induced by a single injection of STZ in rats.The biochemical methods were used to measure the contents of BG,Cr,BUN,U-GLU and Ccr.【Results】Modeling after the success,through the biochemical indicators result comparison,irbesartan-treated group has protection on STZ diabetic rats kidney function compared with other groups,biochemical indexes mean difference is statistically significant(P0.05),pathology examination and electron microscopy examination results are obvious curative effect.【Conclusion】Compared to the diabetic model group,irbesartan has protective effects on kidneys injure of streptozotocin-induced diabetic rats.

Key concepts: Irbesartan, Streptozotocin, Diabetic nephropathy, Medicine, Internal medicine, Diabetes mellitus, Endocrinology, Kidney

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective Effects of Irbesartan on Diabetic Nephropathy in Streptozotocin-induced Diabetic Rats — Research Paper | ScholarLens